These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21135828)

  • 1. Putting stem cells to the test.
    Dolgin E
    Nat Med; 2010 Dec; 16(12):1354-7. PubMed ID: 21135828
    [No Abstract]   [Full Text] [Related]  

  • 2. Reconsidering pluripotency tests: do we still need teratoma assays?
    Buta C; David R; Dressel R; Emgård M; Fuchs C; Gross U; Healy L; Hescheler J; Kolar R; Martin U; Mikkers H; Müller FJ; Schneider RK; Seiler AE; Spielmann H; Weitzer G
    Stem Cell Res; 2013 Jul; 11(1):552-62. PubMed ID: 23611953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making it personal: the prospects for autologous pluripotent stem cell-derived therapies.
    Blair NF; Barker RA
    Regen Med; 2016 Jul; 11(5):423-5. PubMed ID: 27346669
    [No Abstract]   [Full Text] [Related]  

  • 4. A call to standardize teratoma assays used to define human pluripotent cell lines.
    Müller FJ; Goldmann J; Löser P; Loring JF
    Cell Stem Cell; 2010 May; 6(5):412-4. PubMed ID: 20452314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined chemical and genetic approach for the generation of induced pluripotent stem cells.
    Shi Y; Do JT; Desponts C; Hahm HS; Schöler HR; Ding S
    Cell Stem Cell; 2008 Jun; 2(6):525-8. PubMed ID: 18522845
    [No Abstract]   [Full Text] [Related]  

  • 6. Induced pluripotent stem cells: it's like déjà vu all over again.
    Schenke-Layland K; MacLellan WR
    Circulation; 2009 Oct; 120(15):1462-4. PubMed ID: 19786628
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury.
    Lukovic D; Stojkovic M; Moreno-Manzano V; Bhattacharya SS; Erceg S
    Stem Cells Dev; 2014 Jan; 23(1):1-4. PubMed ID: 23980630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium.
    Swijnenburg RJ; Tanaka M; Vogel H; Baker J; Kofidis T; Gunawan F; Lebl DR; Caffarelli AD; de Bruin JL; Fedoseyeva EV; Robbins RC
    Circulation; 2005 Aug; 112(9 Suppl):I166-72. PubMed ID: 16159810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nanotechnology in induced pluripotent and embryonic stem cells research.
    Chen L; Qiu R; Li L
    J Biomed Nanotechnol; 2014 Dec; 10(12):3431-61. PubMed ID: 26000365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genes involved in tumor-like properties of embryonic stem cells.
    Takahashi K; Ichisaka T; Yamanaka S
    Methods Mol Biol; 2006; 329():449-58. PubMed ID: 16846009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified method for implantation of pluripotent stem cells under the rodent kidney capsule.
    Zhu F; Sun B; Wen Y; Wang Z; Reijo Pera R; Chen B
    Stem Cells Dev; 2014 Sep; 23(17):2119-25. PubMed ID: 24800694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will human embryonic stem cell therapies finally grow up?
    McCarthy A
    Chem Biol; 2009 May; 16(5):471-2. PubMed ID: 19477410
    [No Abstract]   [Full Text] [Related]  

  • 13. Stem cell therapy market.
    Syed BA; Evans JB
    Nat Rev Drug Discov; 2013 Mar; 12(3):185-6. PubMed ID: 23449299
    [No Abstract]   [Full Text] [Related]  

  • 14. Stem cells from somatic cell nuclear transfer: research to unlock the body's potential for self-repair.
    Neaves WB
    Mo Med; 2005; 102(1):14-7. PubMed ID: 15754612
    [No Abstract]   [Full Text] [Related]  

  • 15. The tumorigenicity of diploid and aneuploid human pluripotent stem cells.
    Blum B; Benvenisty N
    Cell Cycle; 2009 Dec; 8(23):3822-30. PubMed ID: 19887907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells for the treatment of heart failure.
    Menasché P; Vanneaux V
    Curr Res Transl Med; 2016; 64(2):97-106. PubMed ID: 27316393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation.
    Chung S; Shin BS; Hedlund E; Pruszak J; Ferree A; Kang UJ; Isacson O; Kim KS
    J Neurochem; 2006 Jun; 97(5):1467-80. PubMed ID: 16696855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells: an emerging technology platform and the Gartner hype cycle.
    Mason C; Manzotti E
    Regen Med; 2009 May; 4(3):329-31. PubMed ID: 19438302
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular alchemy: induced pluripotent stem cells retain epigenetic memory.
    Jandial R; Levy ML
    World Neurosurg; 2011 Jan; 75(1):5-6. PubMed ID: 21492641
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.